A larger study done on 7878 variants representing 60 distinct tumour sites from the IARC TP53 Database concludes that missense mutations are IHC positive while nonsense mutations, frameshift mutations and deletions were immunonegative [35]. The gene discussed is TP53; the disease is neoplasm.